Compare stocks

Evaluate stocks side by side, to find the best fit for your investment goals.
ChemoMetec A/S is a biotechnology and life sciences company that specializes in the development, production, and sale of high-quality instruments for cell counting and analysis. Located in Denmark, the company serves various sectors, including research institutions, academic laboratories, and pharmaceutical companies. Its product portfolio includes advanced cell counters and analyzers, such as the NucleoCounter series, which are utilized for precise and reliable cell counting across multiple applications. Established in 1997, ChemoMetec has positioned itself through innovative technology that focuses on accuracy and ease of use. The company operates with a global reach, serving customers through both direct sales and a network of distributors.
View stock
VS
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
View stock

Stock highlights

Stock comparison highlights
Stock name
ChemoMetec A/SEli Lilly
Last price
kr 611.00$1,417.54
Currency
DKK
USD
kr 11B$1.3T
52.6746.01
kr 11.60$30.81
1.390.45
0$6.69
00.49%
Sector
HealthHealth
Employees
17450,000
Ticker
DKr CHEMM$LLY
Primary listing
CSENYSE

Performance

CumulativeRolling yearsLump sum investment

Invest in DKrCHEMM or $LLY on Lightyear

Save on broker fees and invest in 6000+ stocks and funds. When you invest, your capital is at risk.